Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19.

Christoph C Kaufmann,Amro Ahmed,Marie Muthspiel,Isabella Rostocki,Edita Pogran,David Zweiker,Achim Leo Burger,Bernhard Jäger,Gabriele Aicher,Alexander O Spiel,Florian Vafai-Tabrizi,Michael Gschwantler,Peter Fasching,Johann Wojta,Kurt Huber

Journal of clinical medicine（2023）

引用 1|浏览13

暂无评分

摘要

In our study population of hospitalized patients with COVID-19, IL-32 and IL-34 did not show any associations with CV disease or 28-day mortality in the context of COVID-19. Patients with multiple CV diseases, however, had a significantly increased risk of short-term mortality.

查看译文

关键词

COVID-19,CV disease,interleukin-32,interleukin-34,short-term mortality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要